ELUSYS THERAPEUTICS INC

PARSIPPANY, NEW JERSEY 070544612

$122.17M
Total Contract Value
17 awards
First Award
Apr 7, 2022
Last Award
Aug 22, 2025
Business Size
other than small
CAGE Code
1WEK8

Top Industries (NAICS)

NAICS CodeObligationsAwards
325412$123.61M8
541711$131K3

Contract Awards

9 awards found

75A50324C00006
Department of Health and Human Services
$55.27M
Aug 22, 2025

ANTHIM (OBILTOXAXIMAB)

NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURINGFY2025
HHSO100201000026C
Department of Health and Human Services
$-499,207.77
Aug 8, 2024

ELUSYS 0026C MOD#1 9 DE-OB CANCELLING FUNDS

NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2024
HHSO100201100034C
Department of Health and Human Services
$-282,172.97
Aug 6, 2024

THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO DE-OBLIGATE CANCELING FUNDS FROM REQUISITION OS212728 OF $282,172.97, UPDATE SECTION F.2. DELIVERABLES, AND G.5. INVOICES/FINANCING REQUEST AND CONTRACT FINANCIAL REPORTING.

NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2024
75A50324C00006
Department of Health and Human Services
$55.07M
May 14, 2024

ANTHIM - RE-OBLIGATE FUNDS TO REALIGN OC

NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURINGFY2024
75A50324C00006
Department of Health and Human Services
$-55,065,963
May 10, 2024

DE-OBLIGATE FUNDS FROM CLIN 0001 AND 0004 TO REALIGN OBJECT CLASS CODES

NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURINGFY2024
75A50324C00006
Department of Health and Human Services
$69.25M
Apr 30, 2024

ANTHIM (OBILTOXAXIMAB)

NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURINGFY2024
75A50121C00073
Department of Health and Human Services
$-86,000
Mar 12, 2024

MANUFACTURE AND DELIVERY OF ANTHIM (OBILTOXAXIMAB)600MG/6ML INJECTION, AN ANTHRAX ANTITOXIN COUNTERMEASURE

NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURINGFY2024
75A50121C00073
Department of Health and Human Services
$-830,800
Apr 5, 2023

MANUFACTURE AND DELIVERY OF ANTHIM (OBILTOXAXIMAB)600MG/6ML INJECTION, AN ANTHRAX ANTITOXIN COUNTERMEASURE

NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURINGFY2023
HHSO100201100034C
Department of Health and Human Services
$912K
Apr 25, 2022

TO OBLIGATE FUNDING FOR INDIRECT RATE ADJUSTMENTS FOR 2018, 2019, AND 2020.

NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2022

Business Details

UEI
ELP1DCK8L191
CAGE Code
1WEK8
Address
4 CENTURY DR STE 260
PARSIPPANY, NJ 070544612
Congressional District
NJ-11

Parent Company

ELUSYS THERAPEUTICS INC

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov